Peter Feinberg - Aug 3, 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
By: /s/ Michael D. Bookman, Attorney-in-Fact for Peter Feinberg
Stock symbol
IMRX
Transactions as of
Aug 3, 2021
Transactions value $
$4,375,005
Form type
4
Date filed
8/4/2021, 06:06 AM
Previous filing
Sep 13, 2021
Next filing
Sep 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Conversion of derivative security +134K +107.93% 257K Aug 3, 2021 See Foonote F1, F2
transaction IMRX Class A Common Stock Purchase $1.94M +129K +50.2% $15.00 386K Aug 3, 2021 See Foonote F2
transaction IMRX Class A Common Stock Conversion of derivative security +123K +54.92% 347K Aug 3, 2021 See Foonote F1, F3
transaction IMRX Class A Common Stock Purchase $1.94M +129K +37.18% $15.00 477K Aug 3, 2021 See Foonote F3
transaction IMRX Class A Common Stock Conversion of derivative security +82.1K 82.1K Aug 3, 2021 See Foonote F1, F4
transaction IMRX Class A Common Stock Purchase $500K +33.3K +40.6% $15.00 115K Aug 3, 2021 See Foonote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Series A Preferred Stock Conversion of derivative security -103K -100% 0 Aug 3, 2021 Class A Common Stock 103K See footnote F1, F2
transaction IMRX Series A Preferred Stock Conversion of derivative security -92.5K -100% 0 Aug 3, 2021 Class A Common Stock 92.5K See footnote F1, F3
transaction IMRX Series A Preferred Stock Conversion of derivative security -51.5K -100% 0 Aug 3, 2021 Class A Common Stock 51.5K See footnote F1, F4
transaction IMRX Series B Preferred Stock Conversion of derivative security -30.6K -100% 0 Aug 3, 2021 Class A Common Stock 30.6K See footnote F1, F2
transaction IMRX Series B Preferred Stock Conversion of derivative security -30.6K -100% 0 Aug 3, 2021 Class A Common Stock 30.6K See footnote F1, F3
transaction IMRX Series B Preferred Stock Conversion of derivative security -30.6K -100% 0 Aug 3, 2021 Class A Common Stock 30.6K See footnote F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.
F2 Mr. Feinberg is a General Partner of PF Associates L.P.
F3 Mr. Feinberg is a General Partner of PEF LLC.
F4 Mr. Feinberg is a General Partner of S4K Investments LLC.